Breaking News Instant updates and real-time market news.

NAVB

Navidea

$0.14 /

-0.0096 (-6.63%)

07:38
04/08/19
04/08
07:38
04/08/19
07:38

Navidea says prepared to initiate NAV3-31 study after FDA feedback

Navidea Biopharmaceuticals announced that it received feedback from the U.S Food and Drug Administration regarding the company's planned clinical studies that will evaluate joint disease in patients with Rheumatoid Arthritis and monitor patient response to therapy. The company's proposed RA studies were discussed with the FDA during an in-person meeting, and through follow-up collaborative efforts. The FDA has communicated that the first study, a Phase 2b trial, is aligned with expectations for the studies and that they will continue to work with Navidea as we progress into Phase 3 clinical trials. The company is now prepared to initiate this study, NAV3-31. This study will also provide confirmatory support necessary to initiate Navidea's Phase 3 study program which was also presented to the FDA. The pivotal Phase 3 study program will assess joint disease status and monitor patient response to therapy.

TODAY'S FREE FLY STORIES

Earnings
Tivity Health sees FY20 revenue $1.243B-$1.285B, consensus $1.34B  16:04
02/19/20
02/19
16:04
02/19/20
16:04
TVTY

Tivity Health

$22.98 /

+0.13 (+0.57%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Avis Budget sees FY20 adj. EPS $3.75-$4.75, consensus $3.99 » 16:04
02/19/20
02/19
16:04
02/19/20
16:04
CAR

Avis Budget

$42.73 /

+1.39 (+3.36%)

Sees FY20 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Tivity Health reports Q4 adjusted EPS 40c, consensus 55c » 16:04
02/19/20
02/19
16:04
02/19/20
16:04
TVTY

Tivity Health

$22.98 /

+0.13 (+0.57%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
SolarEdge names Zivi Lando to board of directors » 16:04
02/19/20
02/19
16:04
02/19/20
16:04
SEDG

SolarEdge

$127.55 /

+19.15 (+17.67%)

SolarEdge Technologies…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Cimarex Energy reports Q4 non-GAAP EPS $1.18, consensus $1.23 » 16:04
02/19/20
02/19
16:04
02/19/20
16:04
XEC

Cimarex Energy

$40.92 /

+2.045 (+5.26%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
OraSure reports Q4 EPS 4c, consensus 7c » 16:03
02/19/20
02/19
16:03
02/19/20
16:03
OSUR

OraSure

$7.13 /

+0.56 (+8.52%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Syndicate
Axovant files to sell common stock and pre-funded warrants, no amount given » 16:03
02/19/20
02/19
16:03
02/19/20
16:03
AXGT

Axovant

$4.45 /

+0.15 (+3.49%)

SVB Leerink is acting as…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Avis Budget reports Q4 adj. EPS 73c, consensus 50c » 16:03
02/19/20
02/19
16:03
02/19/20
16:03
CAR

Avis Budget

$42.53 /

+1.19 (+2.88%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Crowdstrike names Michael Sentonas CTO » 16:03
02/19/20
02/19
16:03
02/19/20
16:03
CRWD

Crowdstrike

$66.14 /

+0.11 (+0.17%)

CrowdStrike announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Cimarex Energy sees FY20 CapEx $1.25-$1.35B » 16:03
02/19/20
02/19
16:03
02/19/20
16:03
XEC

Cimarex Energy

$40.90 /

+2.025 (+5.21%)

Includes drilling and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Endologix sees FY20 revenue at least $145M, consensus $150.02M » 16:03
02/19/20
02/19
16:03
02/19/20
16:03
ELGX

Endologix

$0.88 /

+0.0402 (+4.79%)

Sees 2020 operating…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Sleep Number sees FY20 EPS $3.10, consensus $2.95 » 16:02
02/19/20
02/19
16:02
02/19/20
16:02
SNBR

Sleep Number

$56.55 /

+0.3 (+0.53%)

Sees FY20 revenue growth…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Endologix reports Q4 EPS (40c), consensus (68c) » 16:02
02/19/20
02/19
16:02
02/19/20
16:02
ELGX

Endologix

$0.88 /

+0.0402 (+4.79%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Tivity Health CEO Donato Tramuto departs, Bob Greczyn named interim CEO » 16:02
02/19/20
02/19
16:02
02/19/20
16:02
TVTY

Tivity Health

$22.98 /

+0.13 (+0.57%)

Tivity Health announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Sleep Number reports Q4 EPS 82c, consensus 75c » 16:02
02/19/20
02/19
16:02
02/19/20
16:02
SNBR

Sleep Number

$56.49 /

+0.24 (+0.43%)

Reports Q4 revenue $441M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Cyberoptics sees Q1 revenue $15.0M-$16.5M, consensus $14.04M  16:01
02/19/20
02/19
16:01
02/19/20
16:01
CYBE

Cyberoptics

$22.95 /

+0.835 (+3.78%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Cyberoptics reports Q4 EPS 2c, consensus 2c » 16:01
02/19/20
02/19
16:01
02/19/20
16:01
CYBE

Cyberoptics

$22.95 /

+0.835 (+3.78%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Piper staying on Integra LifeSciences sidelines due to competition » 15:44
02/19/20
02/19
15:44
02/19/20
15:44
IART

Integra LifeSciences

$60.89 /

+2.055 (+3.49%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Vericity Inc trading resumes  15:38
02/19/20
02/19
15:38
02/19/20
15:38
 
Hot Stocks
GSX Techedu surges after Q4 results » 15:34
02/19/20
02/19
15:34
02/19/20
15:34
GSX

GSX Techedu

$44.79 /

+6.93 (+18.30%)

Shares of GSX Techedu…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Options
SolarEdge options imply 17.2% move in share price post-earnings » 15:34
02/19/20
02/19
15:34
02/19/20
15:34
SEDG

SolarEdge

$126.00 /

+17.6 (+16.24%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Google to move U.K. users' accounts away from EU privacy oversight, Reuters says » 15:33
02/19/20
02/19
15:33
02/19/20
15:33
GOOG

Alphabet

$1,529.39 /

+10.12 (+0.67%)

, GOOGL

Alphabet Class A

$1,527.92 /

+9.06 (+0.60%)

Google intends to move…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Vericity Inc trading halted, volatility trading pause  15:33
02/19/20
02/19
15:33
02/19/20
15:33
 
Recommendations
Analog Devices price target raised to $140 from $125 at Oppenheimer » 15:20
02/19/20
02/19
15:20
02/19/20
15:20
ADI

Analog Devices

$124.18 /

+5.68 (+4.79%)

Oppenheimer analyst Rick…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Options
Stamps.com options imply 27.2% move in share price post-earnings » 15:19
02/19/20
02/19
15:19
02/19/20
15:19
STMP

Stamps.com

$95.54 /

+3.48 (+3.78%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.